Cargando…
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380905/ https://www.ncbi.nlm.nih.gov/pubmed/28282031 http://dx.doi.org/10.1038/bcj.2017.21 |
| _version_ | 1782519834173505536 |
|---|---|
| author | Uy, G L Rettig, M P Stone, R M Konopleva, M Y Andreeff, M McFarland, K Shannon, W Fletcher, T R Reineck, T Eades, W Stockerl-Goldstein, K Abboud, C N Jacoby, M A Westervelt, P DiPersio, J F |
| author_facet | Uy, G L Rettig, M P Stone, R M Konopleva, M Y Andreeff, M McFarland, K Shannon, W Fletcher, T R Reineck, T Eades, W Stockerl-Goldstein, K Abboud, C N Jacoby, M A Westervelt, P DiPersio, J F |
| author_sort | Uy, G L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5380905 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53809052017-05-01 A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia Uy, G L Rettig, M P Stone, R M Konopleva, M Y Andreeff, M McFarland, K Shannon, W Fletcher, T R Reineck, T Eades, W Stockerl-Goldstein, K Abboud, C N Jacoby, M A Westervelt, P DiPersio, J F Blood Cancer J Letter to the Editor Nature Publishing Group 2017-03 2017-03-10 /pmc/articles/PMC5380905/ /pubmed/28282031 http://dx.doi.org/10.1038/bcj.2017.21 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Uy, G L Rettig, M P Stone, R M Konopleva, M Y Andreeff, M McFarland, K Shannon, W Fletcher, T R Reineck, T Eades, W Stockerl-Goldstein, K Abboud, C N Jacoby, M A Westervelt, P DiPersio, J F A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia |
| title | A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia |
| title_full | A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia |
| title_fullStr | A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia |
| title_full_unstemmed | A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia |
| title_short | A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia |
| title_sort | phase 1/2 study of chemosensitization with plerixafor plus g-csf in relapsed or refractory acute myeloid leukemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380905/ https://www.ncbi.nlm.nih.gov/pubmed/28282031 http://dx.doi.org/10.1038/bcj.2017.21 |
| work_keys_str_mv | AT uygl aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT rettigmp aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT stonerm aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT konoplevamy aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT andreeffm aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT mcfarlandk aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT shannonw aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT fletchertr aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT reineckt aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT eadesw aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT stockerlgoldsteink aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT abboudcn aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT jacobyma aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT westerveltp aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT dipersiojf aphase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT uygl phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT rettigmp phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT stonerm phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT konoplevamy phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT andreeffm phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT mcfarlandk phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT shannonw phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT fletchertr phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT reineckt phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT eadesw phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT stockerlgoldsteink phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT abboudcn phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT jacobyma phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT westerveltp phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia AT dipersiojf phase12studyofchemosensitizationwithplerixaforplusgcsfinrelapsedorrefractoryacutemyeloidleukemia |